Literature DB >> 14970396

Biostable aptamers with antagonistic properties to the neuropeptide nociceptin/orphanin FQ.

Dirk Faulhammer1, Bernd Eschgfäller, Sandra Stark, Petra Burgstaller, Werner Englberger, Jeannette Erfurth, Frank Kleinjung, Johanna Rupp, Sebastian Dan Vulcu, Werner Schröder, Stefan Vonhoff, Hermann Nawrath, Clemens Gillen, Sven Klussmann.   

Abstract

The neuropeptide nociceptin/orphanin FQ (N/OFQ), the endogenous ligand of the opioid receptor-like 1 (ORL1) receptor, has been shown to play a prominent role in the regulation of several biological functions such as pain and stress. Here we describe the isolation and characterization of N/OFQ binding biostable RNA aptamers (Spiegelmers) using a mirror-image in vitro selection approach. Spiegelmers are L-enantiomeric oligonucleotide ligands that display high affinity and specificity to their targets and high resistance to enzymatic degradation compared to D-oligonucleotides. A representative Spiegelmer from the selections performed was size-minimized to two distinct sequences capable of high affinity binding to N/OFQ. The Spiegelmers were shown to antagonize binding of N/OFQ to the ORL1 receptor in a binding-competition assay. The calculated IC(50) values for the Spiegelmers NOX 2149 and NOX 2137a/b were 110 nM and 330 nM, respectively. The competitive antagonistic properties of these Spiegelmers were further demonstrated by their effective and specific inhibition of G-protein activation in two additional models. The Spiegelmers antagonized the N/OFQ-induced GTPgammaS incorporation into cell membranes of a CHO-K1 cell line expressing the human ORL1 receptor. In oocytes from Xenopus laevis, NOX 2149 showed an antagonistic effect to the N/OFQ-ORL 1 receptor system that was functionally coupled with G-protein-regulated inwardly rectifying K(+) channels.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14970396      PMCID: PMC1370946          DOI: 10.1261/rna.5186504

Source DB:  PubMed          Journal:  RNA        ISSN: 1355-8382            Impact factor:   4.942


  56 in total

1.  Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase.

Authors:  C Tuerk; L Gold
Journal:  Science       Date:  1990-08-03       Impact factor: 47.728

2.  In vitro selection of RNA molecules that bind specific ligands.

Authors:  A D Ellington; J W Szostak
Journal:  Nature       Date:  1990-08-30       Impact factor: 49.962

3.  A thermodynamic study of unusually stable RNA and DNA hairpins.

Authors:  V P Antao; S Y Lai; I Tinoco
Journal:  Nucleic Acids Res       Date:  1991-11-11       Impact factor: 16.971

4.  Agonistic effects of the opioid buprenorphine on the nociceptin/OFQ receptor.

Authors:  P Bloms-Funke; C Gillen; A J Schuettler; S Wnendt
Journal:  Peptides       Date:  2000-07       Impact factor: 3.750

Review 5.  Probing the structure of RNAs in solution.

Authors:  C Ehresmann; F Baudin; M Mougel; P Romby; J P Ebel; B Ehresmann
Journal:  Nucleic Acids Res       Date:  1987-11-25       Impact factor: 16.971

6.  Synthesis and properties of mirror-image DNA.

Authors:  H Urata; E Ogura; K Shinohara; Y Ueda; M Akagi
Journal:  Nucleic Acids Res       Date:  1992-07-11       Impact factor: 16.971

7.  Selection in vitro of an RNA enzyme that specifically cleaves single-stranded DNA.

Authors:  D L Robertson; G F Joyce
Journal:  Nature       Date:  1990-03-29       Impact factor: 49.962

8.  GnRH binding RNA and DNA Spiegelmers: a novel approach toward GnRH antagonism.

Authors:  Susanne Leva; Andrea Lichte; Jens Burmeister; Peter Muhn; Birgit Jahnke; Dirk Fesser; Jeannette Erfurth; Petra Burgstaller; Sven Klussmann
Journal:  Chem Biol       Date:  2002-03

9.  In vitro selection of RNA ligands to substance P.

Authors:  D Nieuwlandt; M Wecker; L Gold
Journal:  Biochemistry       Date:  1995-04-25       Impact factor: 3.162

10.  Modified RNA sequence pools for in vitro selection.

Authors:  Y Lin; Q Qiu; S C Gill; S D Jayasena
Journal:  Nucleic Acids Res       Date:  1994-12-11       Impact factor: 16.971

View more
  9 in total

1.  Inhibition of stimulated meningeal blood flow by a calcitonin gene-related peptide binding mirror-image RNA oligonucleotide.

Authors:  Thomas Denekas; Markus Tröltzsch; Axel Vater; Sven Klussmann; Karl Messlinger
Journal:  Br J Pharmacol       Date:  2006-04-24       Impact factor: 8.739

2.  In vivo biodistribution and pharmacokinetics of 18F-labelled Spiegelmers: a new class of oligonucleotidic radiopharmaceuticals.

Authors:  Raphaël Boisgard; Bertrand Kuhnast; Stefan Vonhoff; Chéraz Younes; Françoise Hinnen; Jean-Marc Verbavatz; Bernard Rousseau; Jens Peter Fürste; Britta Wlotzka; Frédéric Dollé; Sven Klussmann; Bertrand Tavitian
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-12-22       Impact factor: 9.236

3.  Capillary electrophoresis-SELEX selection of catalytic DNA aptamers for a small-molecule porphyrin target.

Authors:  Jing Yang; Michael T Bowser
Journal:  Anal Chem       Date:  2013-01-14       Impact factor: 6.986

4.  In vitro selection using a dual RNA library that allows primerless selection.

Authors:  Florian Jarosch; Klaus Buchner; Sven Klussmann
Journal:  Nucleic Acids Res       Date:  2006-07-19       Impact factor: 16.971

Review 5.  Nucleic Acid Aptamers: Emerging Applications in Medical Imaging, Nanotechnology, Neurosciences, and Drug Delivery.

Authors:  Pascal Röthlisberger; Cécile Gasse; Marcel Hollenstein
Journal:  Int J Mol Sci       Date:  2017-11-16       Impact factor: 5.923

Review 6.  In vitro evolution of chemically-modified nucleic acid aptamers: Pros and cons, and comprehensive selection strategies.

Authors:  Farhana Lipi; Suxiang Chen; Madhuri Chakravarthy; Shilpa Rakesh; Rakesh N Veedu
Journal:  RNA Biol       Date:  2016-10-07       Impact factor: 4.652

7.  Paclitaxel-loaded and A10-3.2 aptamer-targeted poly(lactide-co-glycolic acid) nanobubbles for ultrasound imaging and therapy of prostate cancer.

Authors:  Meng Wu; Ying Wang; Yiru Wang; Mingbo Zhang; Yukun Luo; Jie Tang; Zhigang Wang; Dong Wang; Lan Hao; Zhibiao Wang
Journal:  Int J Nanomedicine       Date:  2017-07-26

8.  Ultrasound-mediated nanobubble destruction (UMND) facilitates the delivery of A10-3.2 aptamer targeted and siRNA-loaded cationic nanobubbles for therapy of prostate cancer.

Authors:  Meng Wu; Hongyun Zhao; Liang Guo; Yiru Wang; Jiao Song; Xueli Zhao; Chongyan Li; Lan Hao; Dong Wang; Jie Tang
Journal:  Drug Deliv       Date:  2018-11       Impact factor: 6.419

Review 9.  Aptamers as therapeutics.

Authors:  Anthony D Keefe; Supriya Pai; Andrew Ellington
Journal:  Nat Rev Drug Discov       Date:  2010-07       Impact factor: 84.694

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.